ERBB2 and breast carcinoma: These studies showed that upregulation of genes PDE7B, ELMO1, UPK1A and GRIK2, that were upregulated in BTSH and downregulated in BTRH cells, correlated with a favorable prognosis in HER2+ breast cancer patients (Fig. 4A and B).